A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

463 indexed citations

Abstract

loading...

About

This paper, published in 2013, received 463 indexed citations. Written by Caroline M. Apovian, Louis J. Aronne, Domenica Rubino, Christopher D. Still, Holly R. Wyatt, Colleen Burns, Dennis Kim and Eduardo Dunayevich covering the research area of Endocrine and Autonomic Systems, Clinical Psychology and Pharmacology. It is primarily cited by scholars working on Pharmacology (392 citations), Endocrinology, Diabetes and Metabolism (282 citations) and Physiology (217 citations). Published in Obesity.

Countries where authors are citing A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Specialization
Citations

This map shows the geographic impact of A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) more than expected).

Fields of papers citing A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II). Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/oby.20309.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration Breakdown of academic impact, for the paper Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage–Derived VEGFA Breakdown of academic impact, for the paper Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems Breakdown of academic impact, for the paper Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches Breakdown of academic impact, for the paper The Optical Properties of Ice and Snow in the Arctic Basin Breakdown of academic impact, for the paper Socially aware motion planning with deep reinforcement learning Breakdown of academic impact, for the paper Mutational Evidence for the Critical Role of CBF Transcription Factors in Cold Acclimation in Arabidopsis Breakdown of academic impact, for the paper Cholangiocarcinoma Breakdown of academic impact, for the paper Advanced Oxidation Process with Peracetic Acid and Fe(II) for Contaminant Degradation Breakdown of academic impact, for the paper Chemometrics, mathematics and statistics in chemistry
Rankless by CCL
2026